AF-2364 is a prospective spermicide candidate.

Hui Wang1, Xiang-Xiang Chen, Li-Rong Wang

  • 1Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing 210029, China.

Summary

AF-2364, a Lonidamine (LND) analogue, specifically inhibits human sperm motility by targeting mitochondrial pores. This compound decreases sperm energy production and shows potential as a novel spermicide candidate for male contraception.